While numerous proof-of-concept candidate molecules have been disclosed (3443), the only approved example of multi-receptor agonism for obesity and T2D is the dual GLP-1R/GIPR co-agonist tirzepatide (marketed as Mounjaro and Zepbound ) (34, 44)
doi: 10.1016/j.jmb.2020.01.037, 61
Women have less dehydrogenase, an enzyme that breaks down alcohol in the stomach
The safety, quality, and clinical support behind it do not compare
Also, if you are not satisfied with the injection, you can use hyaluronidase dissolved, very convenient
Another trial showed NAC (600 mg 2 daily) increased cellular glutathione by 35% and reduced oxidative stress markers by 25% [9]